SH (6492.TWO) monthly revenue, September 2026
SH reported revenue of NT$0.00bn for September 2026, up 0.0% from the previous month and down 51.2% from a year earlier. Year-to-date revenue was NT$0.00bn, down 13.3% year on year. It ranked 144 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.00 | 0.0 | -51.2 |